home / stock / imrx / imrx short
Short Information | Immuneering Corporation (NASDAQ:IMRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,756,630 |
Total Actual Volume | 8,394,305 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 87,832 |
Average Short Percentage | 22.67% |
Is there a IMRX Short Squeeze or Breakout about to happen?
See the IMRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-09-2024 | $1.63 | $1.56 | $1.63 | $1.52 | 176,052 | 44,082 | 25.04% |
05-08-2024 | $1.55 | $1.63 | $1.72 | $1.53 | 256,779 | 74,148 | 28.88% |
05-07-2024 | $1.66 | $1.56 | $1.66 | $1.52 | 268,551 | 92,237 | 34.35% |
05-06-2024 | $1.64 | $1.65 | $1.7783 | $1.58 | 315,097 | 116,947 | 37.11% |
05-03-2024 | $1.73 | $1.64 | $1.73 | $1.6 | 340,551 | 81,826 | 24.03% |
05-02-2024 | $1.55 | $1.56 | $1.63 | $1.51 | 313,063 | 81,444 | 26.02% |
05-01-2024 | $1.46 | $1.53 | $1.6 | $1.38 | 951,574 | 128,136 | 13.47% |
04-30-2024 | $1.49 | $1.42 | $1.58 | $1.39 | 573,287 | 111,176 | 19.39% |
04-29-2024 | $1.49 | $1.48 | $1.53 | $1.38 | 596,728 | 93,879 | 15.73% |
04-26-2024 | $1.43 | $1.47 | $1.51 | $1.43 | 295,784 | 42,538 | 14.38% |
04-25-2024 | $1.53 | $1.43 | $1.5428 | $1.4 | 382,352 | 79,237 | 20.72% |
04-24-2024 | $1.61 | $1.5 | $1.65 | $1.47 | 471,224 | 90,619 | 19.23% |
04-23-2024 | $1.71 | $1.63 | $1.73 | $1.6 | 328,220 | 49,122 | 14.97% |
04-22-2024 | $1.77 | $1.72 | $1.79 | $1.69 | 331,241 | 55,628 | 16.79% |
04-19-2024 | $1.79 | $1.8 | $1.82 | $1.56 | 515,620 | 110,776 | 21.48% |
04-18-2024 | $1.89 | $1.77 | $1.89 | $1.76 | 178,106 | 39,966 | 22.44% |
04-17-2024 | $1.87 | $1.86 | $1.97 | $1.82 | 295,376 | 81,068 | 27.45% |
04-16-2024 | $1.89 | $1.84 | $1.96 | $1.75 | 689,968 | 81,651 | 11.83% |
04-15-2024 | $2.07 | $1.915 | $2.08 | $1.89 | 857,129 | 211,012 | 24.62% |
04-12-2024 | $2.08 | $2.1 | $2.14 | $2.03 | 257,603 | 91,138 | 35.38% |
News, Short Squeeze, Breakout and More Instantly...
Immuneering Corporation Company Name:
IMRX Stock Symbol:
NASDAQ Market:
- Reported Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors - - First Patient Dosed in Phase 2a Portion of Phase 1/2a Clinical Trial of IMM-1-104; Initial Data from Multiple IMM-1-104 Phase 2a Arms Expected in 2024 - ...
- Two clinical stage product candidates in development for the treatment of melanoma - - RAS mutant melanoma represents one of five arms in the company’s ongoing Phase 2a clinical study of IMM-1-104 - - Melanoma also being evaluated in ongoing Phase 1/2a clinical study of...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...